Cited by 1,947Receptor Mechanisms and SignalingIon channel regulation and functionNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 3 of the 7 references it cites were found in a registry or an index, and 4 are not checked yet.

Guide to Receptors and Channels (GRAC), 5th edition

Open access

Alexander, SPH, Mathie, A, Peters, JA·2011·British Journal of Pharmacology

DOI 10.1111/j.1476-5381.2011.01649_1.xPMC PMC3315626

Open this paper in CoChat — free account Open PDF

Abstract

The Fifth Edition of the 'Guide to Receptors and Channels' is a compilation of the major pharmacological targets divided into seven sections: G protein-coupled receptors, ligand-gated ion channels, ion channels, catalytic receptors, nuclear receptors, transporters and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside suggestions for further reading. Available alongside this publication is a portal at http://www.GuideToPharmacology.org which is produced in close association with NC-IUPHAR and allows free online access to the information presented in the Fifth Edition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01649_1.x

Cites

3 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects
Kanai, Y., & Hediger, M. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1146-4 · Cited by 450
The thermo‐TRP ion channel family: properties and therapeutic implications
Vay, L., Gu, C., & McNaughton, P. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01601.x · Cited by 313
Guide to Receptors and Channels (GRAC), 4th edition
Alexander, S. P. H., & Peters, J. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00499.x · Cited by 249
Self-citation
The oligomeric state sets GABAB receptor signalling efficacy
Comps‐Agrar, L., Kniazeff, J., Nørskov-Lauritsen, L., Maurel, D., Gassmann, M., Gregor, N., Prézeau, L., Bettler, B., Durroux, T., Trinquet, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.143 · Cited by 103
Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 98
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.
Vanhoutte, P. M., Humphrey, P. P. A., & Spedding, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06936-4 · Cited by 78
The VPAC 2 agonist peptide histidine isoleucine (PHI) up‐regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1 G93A ) by inhibiting caspase‐3 mediated inactivation of GLT‐1a
Goursaud, S., Focant, M. C., Berger, J. V., Nizet, Y., Maloteaux, J., & Hermans, E. (2011) · The FASEB Journal · doi:10.1096/fj.11-182337 · Cited by 14

Show all 2 references

Sorted by citations

Items 401–500 of 1,000

Nicorandil ameliorates ischaemia‐reperfusion injury in the rat kidney
Shimizu, S., Saito, M., Kinoshita, Y., Ohmasa, F., Dimitriadis, F., Shomori, K., Hayashi, A., & Satoh, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01231.x · Cited by 75
Participation of the GABAergic system in the anesthetic effect of Lippia alba (Mill.) N.E. Brown essential oil
Heldwein, C. G., Silva, L. L., Reckziegel, P., Barros, F., Bürger, M. E., Baldisserotto, B., Mallmann, C. A., Schmidt, D., Caron, B. O., & Heinzmann, B. M. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500052 · Cited by 75
The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC
Liptrott, N. J., Penny, M., Bray, P., Sathish, J. G., Khoo, S., Back, D., & Owen, A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00050.x · Cited by 75
Induction of trefoil factor (TFF)1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor‐1: implications for gastric mucosal healing
Hernández, C., Santamatilde, E., McCreath, K. J., Cervera, A., Díez, I., Ortiz‐Masiá, D., Martínez, N., Calatayud, S., Esplugues, J. V., & Barrachina, M. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00044.x · Cited by 75
Impairment of endothelial SKCa channels and of downstream hyperpolarizing pathways in mesenteric arteries from spontaneously hypertensive rats
Weston, A. H., Porter, E. L., Harno, E., & Edwards, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00657.x · Cited by 75
Roflumilast inhibits the release of chemokines and TNF‐α from human lung macrophages stimulated with lipopolysaccharide
Buenestado, A., Grassin‐Delyle, S., Guitard, F., Naline, E., Faisy, C., Israël‐Biet, D., Sage, É., Bellamy, J., Tenor, H., & Devillier, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01667.x · Cited by 74
Niacin: a re‐emerging pharmaceutical for the treatment of dyslipidaemia
Vosper, H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00349.x · Cited by 75
17‐ β Oestradiol prevents cardiovascular dysfunction in post‐menopausal metabolic syndrome by affecting SIRT1 / AMPK / H3 acetylation
Bendale, D. S., Karpe, P. A., Chhabra, R., Shete, S. P., Shah, H., & Tikoo, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12290 · Cited by 75
Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro
Whyte, L., Ford, L., Ridge, S. A., Cameron, G. A., Rogers, M. J., & Ross, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01519.x · Cited by 78
Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis
Hennenberg, M., Trebicka, J., Stark, C., Kohistani, A. Z., Heller, J., & Sauerbruch, T. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00158.x · Cited by 75
Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y 1 and Y 2 receptors
Tough, I. R., Forbes, S. C., Rs, T., Ellis, M., Herzog, H., Bornstein, J. C., & Cox, H. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01401.x · Cited by 74
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2‐arachidonoylglycerol with potential anti‐obesity effects
Bisogno, T., Mahadevan, A., Coccurello, R., Chang, J. W., Allarà, M., Chen, Y., Giacovazzo, G., Lichtman, A. H., Cravatt, B. F., Moles, A., et al. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12013 · Cited by 74
The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease
Edwards, N. C., Steeds, R. P., Chue, C. D., Stewart, P. M., Ferro, C. J., & Townend, J. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04102.x · Cited by 75
Cannabinoid CB2 receptor‐mediated regulation of impulsive‐like behaviour in DBA/2 mice
Navarrete, F., Pérez‐Ortiz, J. M., & Manzanares, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01542.x · Cited by 72
Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen species
Furieri, L. B., Galán, M., Avendaño, M. S., García‐Redondo, A. B., Aguado, A., Martínez, S. G., Cachofeiro, V., Bartolomé, M. V., Alonso, M. J., Vassallo, D. V., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01203.x · Cited by 73
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes
Varani, K., Vincenzi, F., Tosi, A., Targa, M., Masieri, F. F., Ongaro, A., Mattei, M. D., Massari, L., & Pa, B. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00667.x · Cited by 73
Signalling pathways involved in sildenafil‐induced relaxation of human bladder dome smooth muscle
Oger, S., Behr‐Roussel, D., Gorny, D., Lebrét, T., Validire, P., Cathelineau, X., Alexandre, L., & Giuliano, F. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00748.x · Cited by 73
The contribution of reactive oxygen species and p38 mitogen‐activated protein kinase to myofilament oxidation and progression of heart failure in rabbits
Heusch, P., Canton, M., Aker, S., van de Sand, A., Konietzka, I., Rassaf, T., Menazza, S., Brodde, O. E., Lisa, F. D., Heusch, G., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00793.x · Cited by 72
K+depolarization evokes ATP, adenosine and glutamate release from glia in rat hippocampus: a microelectrode biosensor study
Heinrich, A., Andó, R., Turi, G. F., Rózsa, B. J., & Sperlágh, B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01932.x · Cited by 78
ORM ‐10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart
Jost, N., Nagy, N., Corici, C., Kohajda, Z., Horváth, A., Acsai, K., Biliczki, P., Levijoki, J. M., Pollesello, P., Koskelainen, T., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12228 · Cited by 73
Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery
Harikumar, K. G., Wootten, D. L., Pinon, D. I., Koole, C., Ball, A. M., Furness, S. G. B., Graham, B., Dong, M., Christopoulos, A., Miller, L. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205227109 · Cited by 73
ONO ‐2506 inhibits spike–wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation
Yamamura, S., Hoshikawa, M., Kato, D., Saito, H., 昇, 鈴., Niwa, O., & Okada, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02132.x · Cited by 72
Targeting voltage‐gated calcium channels: developments in peptide and small‐molecule inhibitors for the treatment of neuropathic pain
Vink, S., & Alewood, P. F. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02082.x · Cited by 72
Fifteen years of ChEMBL and its role in cheminformatics and drug discovery
Zdrazil, B. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-00963-z · Cited by 72
Tuning Electrical Conduction Along Endothelial Tubes of Resistance Arteries Through Ca 2+ -Activated K + Channels
Behringer, E. J., & Segal, S. S. (2012) · Circulation Research · doi:10.1161/circresaha.111.262592 · Cited by 72
Challenges for and current status of research into positive modulators of AMPA receptors
Ward, S. E., Bax, B. D., & Harries, M. H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00726.x · Cited by 72
Sulphide quinone reductase contributes to hydrogen sulphide metabolism in murine peripheral tissues but not in the CNS
Linden, D., Furne, J. K., Stoltz, G. J., Abdel-Rehim, M. S., Levitt, M., & Szurszewski, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01681.x · Cited by 71
Predicting drug‐induced slowing of conduction and pro‐arrhythmia: identifying the ‘bad’ sodium current blockers
Lu, H. R., Rohrbacher, J., Vlaminckx, E., Ammel, K. V., Yan, G., & Gallacher, D. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00646.x · Cited by 71
Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia
Armogida, M., Nisticò, R., & Mercuri, N. B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01912.x · Cited by 72
Involvement of the endogenous hydrogen sulfide/Cav3.2 T‐type Ca2+ channel pathway in cystitis‐related bladder pain in mice
Matsunami, M., Miki, T., Nishiura, K., Hayashi, Y., Okawa, Y., Nishikawa, H., Sekiguchi, F., Kubo, L., Ozaki, T., Tsujiuchi, T., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02060.x · Cited by 71
The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions
Jurčević, S., Humfrey, C. D. N., Uddin, M., Warrington, S., LARSSON, B. S., & Keen, C. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12724 · Cited by 71
Rapid brain penetration of interleukin‐1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection
Greenhalgh, A. D., Galea, J. P., Dénes, Á., Tyrrell, P. J., & Rothwell, N. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00684.x · Cited by 72
ArachnoServer: a database of protein toxins from spiders
Wood, D., Miljenović, T. M., Cai, S., Raven, R. J., Kaas, Q., Escoubas, P., Herzig, V., Wilson, D. T. R., & King, G. F. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-375 · Cited by 71
Endothelin‐2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer
Ling, L., Maguire, J. J., & Davenport, A. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01786.x · Cited by 70
Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions
Pintér, E., Pozsgai, G., Hajna, Z., Helyes, Z., & Szolcsányi, J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12097 · Cited by 70
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model
Barnes, N. S. A., Mitchell, V. A., Kazantzis, N. P., & Vaughan, C. W. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13337 · Cited by 72
Cell Volume Regulation in Chondrocytes
Lewis, R., Feetham, C. H., & Barrett‐Jolley, R. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335847 · Cited by 70
P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers
Antonio, L., Stewart, A. P., Xu, X., Varanda, W. A., Murrell‐Lagnado, R. D., & Edwardson, J. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01303.x · Cited by 69
New horizons in the treatment of cystic fibrosis
Cuthbert, A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01137.x · Cited by 69
Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review
Dell’Orto, V., Belotti, E. A., Goeggel‐Simonetti, B., Simonetti, G. D., Ramelli, G. P., Bianchetti, M. G., & Lava, S. A. G. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12283 · Cited by 69
Effects of cytochrome P450 3A (CYP3A) and the drug transporters P‐glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir
van Waterschoot, R., ter Heine, R., Wagenaar, E., van der Kruijssen, C., Rooswinkel, R. W., Huitema, A. D. R., Beijnen, J. H., & Schinkel, A. H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00759.x · Cited by 69
Inhibition of human recombinant T‐type calcium channels by the endocannabinoid N‐arachidonoyl dopamine
Ross, H., Gilmore, A. J., & Connor, M. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00072.x · Cited by 69
P2Y 1 receptors mediate inhibitory neuromuscular transmission in the rat colon
Grasa, L., Gil, V., Gallego, D., Martín, M. T., & Jiménez, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00454.x · Cited by 69
Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesis
Eckertova, M., Ondrejcakova, M., Krskova, K., Zorad, S., & Jezova, D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01037.x · Cited by 68
Impact of species variability and ‘probe‐dependence’ on the detection andin vivovalidation of allosteric modulation at the M4muscarinic acetylcholine receptor
Suratman, S., Leach, K., Sexton, P. M., Felder, C. C., Loiacono, R. E., & Christopoulos, A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01184.x · Cited by 68
Comparison of the I Kr blockers moxifloxacin, dofetilide and E‐4031 in five screening models of pro‐arrhythmia reveals lack of specificity of isolated cardiomyocytes
Nalos, L., Varkevisser, R., Jonsson, M., Houtman, M. J. C., Beekman, J. D. M., van der Nagel, R., Thomsen, M. B., Duker, G., Sartipy, P., de Boer, T. P., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01558.x · Cited by 68
Aldosterone affects blood flow and vascular tone regulated by endothelium‐derived NO: therapeutic implications
Toda, N., Nakanishi, S., & Tanabe, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02194.x · Cited by 68
NS 6180, a new KCa 3.1 channel inhibitor prevents T ‐cell activation and inflammation in a rat model of inflammatory bowel disease
Strøbæk, D., Brown, D., Jenkins, D., Chen, Y., Coleman, N., Ando, Y., Chiu, P., Jørgensen, S., Demnitz, J., Wulff, H., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02143.x · Cited by 68
NS309 restores EDHF‐type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats
Brøndum, E., Kold‐Petersen, H., Simonsen, U., & Aalkjær, C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00525.x · Cited by 68
Estrogen Signaling through the G Protein–Coupled Estrogen Receptor Regulates Granulocyte Activation in Fish
Cabas, I., Rodenas, M. C., Abellán, E., Meseguer, J., Mulero, V., & Ayala, A. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301613 · Cited by 68
A role for the sensory neuropeptide calcitonin gene‐related peptide in endothelial cell proliferationin vivo
Mapp, P. I., McWilliams, D. F., Turley, M. J., Hargin, E., & Walsh, D. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01848.x · Cited by 68
Role of G12 proteins in oncogenesis and metastasis
Juneja, J., & Casey, P. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00180.x · Cited by 68
Inhibition of fatty acid amide hydrolase unmasks CB1receptor and TRPV1 channel‐mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey
Kawahara, H., Drew, G., Christie, M., & Vaughan, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01157.x · Cited by 67
Astrocytes in Neural Circuits: Key Factors in Synaptic Regulation and Potential Targets for Neurodevelopmental Disorders
Liu, X., Ying, J., Wang, X., Zheng, Q., Zhao, T., Yoon, S., Yu, W., Yang, D., Yang, F., & Hua, F. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.729273 · Cited by 78
Gene Therapy in Inherited Retinal Diseases: An Update on Current State of the Art
Amato, A., Arrigo, A., Aragona, E., Manitto, M. P., Saladino, A., Bandello, F. M., & Parodi, M. B. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.750586 · Cited by 68
NPY controls fear conditioning and fear extinction by combined action on Y1 and Y2 receptors
Verma, D., Tasan, R. O., Herzog, H., & Sperk, G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01872.x · Cited by 67
Ranolazine selectively blocks persistent current evoked by epilepsy‐associated NaV1.1 mutations
Kahlig, K. M., Lepist, I., Leung, K., Rajamani, S., & George, A. L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00976.x · Cited by 69
Neuroprotective potential of CB1receptor agonists in anin vitromodel of Huntington's disease
Scotter, E. L., Goodfellow, C. E., Graham, E. S., Dragunow, M., & Glass, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00773.x · Cited by 66
Bisphenol A activates Maxi‐K (KCa1.1) channels in coronary smooth muscle
Asano, S., Tune, J. D., & Dick, G. M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00687.x · Cited by 67
β‐Adrenergic receptors stimulate interleukin‐6 production through Epac‐dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts
Chen, C., Du, J., Feng, W., Song, Y., Lü, Z., Xu, M., Li, Z., & Zhang, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01785.x · Cited by 67
Hydrogen sulfide upregulates KATP channel expression in vascular smooth muscle cells of spontaneously hypertensive rats
Sun, Y. K., Huang, Y., Zhang, R., Chen, Q., Chen, J., Zong, Y., Liu, J., Feng, S., Liu, A. D., Holmberg, L., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1227-1 · Cited by 68
An investigation of the safety and pharmacokinetics of the novel TRPV1 antagonist XEN‐D0501 in healthy subjects
Round, P., Priestley, A., & Robinson, J. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04040.x · Cited by 67
GPCR expression in tissues and cells: Are the optimal receptors being used as drug targets?
Insel, P., Snead, A. N., Murray, F., Zhang, L., Yokouchi, H., Katakia, T., Kwon, O., DiMucci, D., & Wilderman, A. S. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01434.x · Cited by 67
Structural determinants in the second intracellular loop of the human cannabinoid CB1receptor mediate selective coupling to Gsand Gi
Chen, X., Yang, W. J., Fan, Y., Luo, J., Hong, K., Wang, Z., Yan, J., Chen, X., Lu, J., Benovic, J., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01006.x · Cited by 66
TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity
Yamamoto, K., Uchida, S., Kitano, K., Fukuhara, N., Okumura-Kitajima, L., Gunji, E., Kozakai, A., Tomoike, H., Kojima, N., Asami, J., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01340.x · Cited by 66
Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure
Kaufling, J., Waltisperger, E., Bourdy, R., Valera, A. M., Veinante, P., Freund‐Mercier, M. J., & Barrot, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00984.x · Cited by 66
Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage
Horiuchi, M., & Mogi, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01167.x · Cited by 66
N‐arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium‐activated potassium channels
Parmar, N., & Ho, W. ‐. V. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00622.x · Cited by 70
GPR55‐dependent and ‐independent ion signalling in response to lysophosphatidylinositol in endothelial cells
Bondarenko, A. I., Waldeck‐Weiermair, M., Naghdi, S., Poteser, M., Malli, R., & Graier, W. F. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00744.x · Cited by 69
β2-Adrenoceptor Agonists Are Required for Development of the Asthma Phenotype in a Murine Model
Thanawala, V. J., Forkuo, G. S., Al‐Sawalha, N. A., Azzegagh, Z., Nguyễn, L., Eriksen, J. L., Tuvim, M. J., Lowder, T., Dickey, B. F., Knoll, B. J., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0364oc · Cited by 66
Imidazoline I 2 receptors: An update
Li, J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.009 · Cited by 70
The role of cholesterol metabolism and various steroid abnormalities in autism spectrum disorders: A hypothesis paper
Gillberg, C., Fernell, E., Kočovská, E., Minnis, H., Bourgeron, T., Thompson, L., & Allely, C. S. (2017) · Autism Research · doi:10.1002/aur.1777 · Cited by 65
A novel µ‐conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors
Favreau, P., Benoit, É., Hocking, H. G., Carlier, L., hoedt, D. D., Leipold, E., Markgraf, R., Schlumberger, S., Córdova, M., Gaertner, H., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01837.x · Cited by 65
Activation of transient receptor potential A1 by a non‐pungent capsaicin‐like compound, capsiate
Shintaku, K., Uchida, K., Suzuki, Y., Zhou, Y., Fushiki, T., Watanabe, T., Yazawa, S., & Tominaga, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01634.x · Cited by 65
Cis‐isomerism and other chemical requirements of steroidal agonists and partial agonists acting at TRPM3 channels
Majeed, Y., Agarwal, A., Naylor, J., Seymour, V., Jiang, S., Muraki, K., Fishwick, C. W. G., & Beech, D. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00892.x · Cited by 63
Access of inhibitory neurosteroids to the NMDA receptor
Borovská, J., Vyklický, V., Kudová, E., Kapras, V., Slavı́ková, B., Hořák, M., Chodounská, H., & Vyklický, L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01816.x · Cited by 64
Ion channels as novel therapeutic targets in the treatment of pain
Mathie, A. A. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01131.x · Cited by 66
Self-citation
Blockade of β‐adrenoceptors restores the GRK2‐mediated adrenal α2‐adrenoceptor–catecholamine production axis in heart failure
Rengo, G., Lymperopoulos, A., Zincarelli, C., Femminella, G. D., Liccardo, D., Pagano, G., de Lucia, C., Cannavò, A., Gargiulo, P., Ferrara, N., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01972.x · Cited by 64
Role of 5‐HT1receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn
Jeong, H., Mitchell, V. A., & Vaughan, C. W. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01685.x · Cited by 64
Short‐term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro‐cognitive benefit in a mouse model of D own's syndrome
Colas, D., Chuluun, B., Warrier, D. R., Blank, M., Wetmore, D. Z., Buckmaster, P. S., Garner, C. C., & Heller, H. C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12169 · Cited by 63
The end of a myth: cloning and characterization of the ovine melatonin MT2 receptor
Cogé, F., Guenin, S., Féry, I., Migaud, M., Devavry, S., Slugocki, C., Legros, C., Ouvry, C., Cohen, W., Renault, N., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00453.x · Cited by 64
Penta‐ O ‐galloyl‐ β ‐ D ‐glucose ameliorates inflammation by inhibiting MyD 88/ NF ‐ κB and MyD 88/ MAPK signalling pathways
Jang, S., Hyam, S. R., Jeong, J., Han, M. J., & Kim, D. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12333 · Cited by 65
Functionally biased signalling properties of 7TM receptors – opportunities for drug development for the ghrelin receptor
Sivertsen, B., Holliday, N. D., Madsen, A. N., & Holst, B. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12361 · Cited by 68
Regional quantification of muscarinic acetylcholine receptors and β‐adrenoceptors in human airways
Ikeda, T., Anisuzzaman, A. S. M., Yoshiki, H., Sasaki, M., Koshiji, T., Uwada, J., Nishimune, A., Itoh, H., & Muramatsu, I. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01881.x · Cited by 64
Tanshinone I enhances learning and memory, and ameliorates memory impairment in mice via the extracellular signal‐regulated kinase signalling pathway
Kim, D. H., Kim, S., Jeon, S. J., Son, K. H., Lee, S., Yoon, B. H., Cheong, J. H., Ko, K. H., & Ryu, J. H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00378.x · Cited by 63
Identification of regions of the P2X7receptor that contribute to human and rat species differences in antagonist effects
Michel, A. D., Clay, W. C., Ng, S., Roman, S. A., Thompson, K. M., Condreay, J. P., Hall, M. D., Holbrook, J. D., Livermore, D. G., & Senger, S. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.306 · Cited by 64
Functional regulation of vascular and platelet activity during thrombosis by nitric oxide and endothelial nitric oxide synthase
Moore, C., Tymvios, C., & Emerson, M. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-11-0764 · Cited by 64
A Continuous, Fluorescence-based Assay of µ-Opioid Receptor Activation in AtT-20 Cells
Knapman, A., Santiago, M., Du, Y. P., Bennallack, P. R., Christie, M. J., & Connor, M. A. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112461376 · Cited by 64
Pre-synaptic glycine GlyT1 transporter - NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions
Musante, V., Summa, M., Cunha, R. A., Raiteri, M., & Pittaluga, A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07223.x · Cited by 63
The contribution of the endogenous TRPV1 ligands 9‐ HODE and 13‐ HODE to nociceptive processing and their role in peripheral inflammatory pain mechanisms
Alsalem, M., Wong, A., Millns, P. J., Arya, P. H., Chan, M. S. L., Bennett, A. J., Barrett, D. A., Chapman, V., & Kendall, D. A. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12092 · Cited by 63
Ketamine‐induced ventricular structural, sympathetic and electrophysiological remodelling: pathological consequences and protective effects of metoprolol
Li, Y., Shi, J., Yang, B., Liu, L., Cl, H., Li, W., Dong, D., Pan, Z., Liu, G., Geng, J., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01635.x · Cited by 64
Altered histamine H3receptor radioligand binding in post‐mortem brain samples from subjects with psychiatric diseases
Jin, C., Anichtchik, O. V., & Panula, P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00149.x · Cited by 63
The role of P2X7 purinergic receptors in inflammatory and nociceptive changes accompanying cyclophosphamide‐induced haemorrhagic cystitis in mice
Jp, M., Silva, R. B. M., Coutinho‐Silva, R., Takiya, C. M., Battastini, A., Morrone, F. B., & Campos, M. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01535.x · Cited by 63
Interplay between statins and PPARs in improving cardiovascular outcomes: a double‐edged sword?
Balakumar, P., & Mahadevan, N. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01597.x · Cited by 63
New perspectives for the treatment of pulmonary hypertension
Baliga, R. S., MacAllister, R. J., & Hobbs, A. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01164.x · Cited by 63
Mechanism of action of species‐selective P2X7receptor antagonists
Michel, A. D., Ng, S., Roman, S. A., Clay, W. C., Dean, D. K., & Walter, D. S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00135.x · Cited by 63
A positive allosteric modulator of α7 n AChR s augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia
Kalappa, B. I., Sun, F., Johnson, S. R., Jin, K., & Uteshev, V. V. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12247 · Cited by 64
Maintenance of Homeostasis in the Aging Hypothalamus: The Central and Peripheral Roles of Succinate
Chen, T. T., Maevsky, E. I., & Uchitel, M. L. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00007 · Cited by 62
Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET
Tohda, C., & Joyashiki, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00313.x · Cited by 62
G Protein–Coupled Receptor Multimers: A Question Still Open Despite the Use of Novel Approaches
Vischer, H. F., Castro, M., & Pin, J. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099440 · Cited by 62

Authors: Alexander, S., Mathie, A., & Peters, J.
Affiliations: University of Nottingham (GB)
Medway School of Pharmacy (GB)
University of Dundee (GB)
ORCID: Mathie, A
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2011-11
Volume: 164
Issue: s1
Pages: S1-324
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1111/j.1476-5381.2011.01649_1.x
PMC: PMC3315626
OpenAlex: W2069380892
Cited by: 1,947
References: 2
Citations by year: 2026: 4 · 2025: 13 · 2024: 12 · 2023: 14 · 2022: 23 · 2021: 19 · 2020: 20 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 47 · 2015: 59 · 2014: 71 · 2013: 191 · 2012: 279
FWCI: 109.61
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: British Journal of Pharmacology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (submittedVersion)
Kent Academic Repository (University of Kent) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: therapeutic target, G protein-coupled receptors, ligand-gated ion channels, ion channels, nuclear receptors, transporters, enzymes, receptor nomenclature, pharmacological tools
MeSH terms: Animals, Humans, Ion Channels, Receptors, Cell Surface, Receptors, Cytoplasmic and Nuclear

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Guide to Receptors and Channels (GRAC), 5th edition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks